Dynavax Technologies
DVAX
#4951
Rank
NZ$3.04 B
Marketcap
NZ$25.90
Share price
0.00%
Change (1 day)
7.82%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -NZ$63.57 Million

According to Dynavax Technologies 's latest financial reports the company's current earnings are NZ$0.33 Billion. In 2024 the company made an earning of NZ$62.9 Million, an increase over its 2023 earnings that were of NZ$3.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$63.57 Million-201.05%
2024 NZ$62.9 M1475.31%
2023 NZ$3.99 M-99.2%
2022 NZ$0.50 B238.78%
2021 NZ$0.14 B-257.89%
2020 -NZ$93.86 Million-58.58%
2019 -NZ$0.23 Billion-9.32%
2018 -NZ$0.25 Billion60.44%
2017 -NZ$0.16 Billion-15.8%
2016 -NZ$0.19 Billion4.22%
2015 -NZ$0.18 Billion16.54%
2014 -NZ$0.16 Billion37.09%
2013 -NZ$0.12 Billion
2010 -NZ$79.51 Million214.85%
2009 -NZ$25.26 Million-37.33%
2008 -NZ$40.3 Million-66.07%
2007 -NZ$0.12 Billion16.92%
2006 -NZ$0.11 Billion170.36%
2005 -NZ$37.58 Million33.39%
2004 -NZ$28.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$19.80 B-35,074.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$13.77 B-24,427.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$3.18 B-5,718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$16.51 B-29,272.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$38.57 B-68,236.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$21.86 B-38,727.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$15.57 B-27,610.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
NZ$34.52 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$3.59 B-6,450.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel